Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 901–1,000 of 1,018
Pasetto, L., Grassano, M., Pozzi, S., Luotti, S., Sammali, E., Migazzi, A., Basso, M., Spagnolli, G., Biasini, E., Micotti, E., et al. (2021) · Brain · doi:10.1093/brain/awab333 · Cited by 37
Tracking the development of agrammatic aphasia: A tensor-based morphometry study
Whitwell, J. L., Duffy, J. R., Machulda, M. M., Clark, H. M., Strand, E. A., Senjem, M. L., Gunter, J. L., Spychalla, A. J., Petersen, R. C., Jack, C. R., et al. (2016) · Cortex · doi:10.1016/j.cortex.2016.09.017 · Cited by 33
Modifiers of GRN -Associated Frontotemporal Lobar Degeneration
Wauters, E., Mossevelde, S. V., van der Zee, J., Cruts, M., & Broeckhoven, C. V. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.08.004 · Cited by 33
Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
Cooper, Y. A., Nachun, D. C., Dokuru, D. R., Yang, Z., Karydas, A. M., Serrero, G., Yue, B., Initiative, A. D. N., Boxer, A. L., Miller, B. L., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.560 · Cited by 35
Davidson, Y. S., Amin, H., Kelley, T., Shi, J., Tian, J., Kumaran, R., Lashley, T., Lees, A. J., DuPlessis, D., Neary, D., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0526-z · Cited by 34
Self-citationThe Role of Progranulin (PGRN) in the Pathogenesis of Ischemic Stroke
Purrahman, D., Shojaeian, A., Poniatowski, Ł. A., Piechowski‐Jóźwiak, B., & Mahmoudian‐Sani, M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01396-8 · Cited by 32
Takahashi, H., Bhagwagar, S. Z., Nies, S. H., Ye, H., Han, X., Chiasseu, M., Wang, G., Mackenzie, I. R., & Strittmatter, S. M. (2024) · Nature Communications · doi:10.1038/s41467-024-45692-3 · Cited by 32
Self-citationReich, M., Simon, M. J., Polke, B., Paris, I., Werner, G., Schrader, C. M., Spieth, L., Davis, S. S., Robinson, S., de Melo, G. L., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj7308 · Cited by 37
Antonell, A., Gil, S., Sánchez-Valle, R., Balasa, M., Bosch, B., Prat, M. C., Chiollaz, A.-C., Fernández, M., Yagüe, J., Molinuevo, J. L., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-112120 · Cited by 31
Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology
Fujita, K., Chen, X., Homma, H., Tagawa, K., Amano, M., Saito, A., Imoto, S., Akatsu, H., Hashizume, Y., Kaibuchi, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02821-z · Cited by 36
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 35
Liu, E., Karpf, L., & Bohl, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.767041 · Cited by 34
Boeve, B. F. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.002 · Cited by 33
Self-citationZhang, K., Li, Y.-J., Feng, D., Zhang, P., Wang, Y., Li, X., Liu, S., Wu, Y., & Zhao, M. (2017) · Scientific Reports · doi:10.1038/srep43594 · Cited by 39
Casterton, R., Hunt, R. J., & Fanto, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.018 · Cited by 38
Ljubenkov, P. A., Edwards, L., Iaccarino, L., La Joie, R., Rojas, J. C., Koestler, M., Harris, B., Boeve, B. F., Borroni, B., van Swieten, J. C., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25584 · Cited by 30
Self-citationNovel CSF biomarkers to discriminate FTLD and its pathological subtypes
del Campo, M., Galimberti, D., Elias, N., Boonkamp, L., Pijnenburg, Y. A., van Swieten, J. C., Watts, K., Paciotti, S., Beccari, T., Hu, W., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.629 · Cited by 30
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
Koga, S., Zhou, X., Murakami, A., Fernandez De Castro, C., Baker, M. C., Rademakers, R., & Dickson, D. W. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12778 · Cited by 30
“GRN sequencing and screening for C9orf72 hexanucleotide repeat expansion were performed as previously described [34,35].”
MethodSelf-citationPathogenic signal peptide variants in the human genome
Guarnizo, S. A. G., Kellogg, M. K., Miller, S. C., Tikhonova, E. B., Karamysheva, Z. N., & Karamyshev, A. L. (2023) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqad093 · Cited by 34
Almeida, M. R., Baldeiras, I., Ribeiro, M. H., Santiago, B., Machado, C., Massano, J., Guimarães, J., Resende Oliveira, C., & Santana, I. (2014) · Neurodegenerative Diseases · doi:10.1159/000352022 · Cited by 30
Genetic Causes of Frontotemporal Degeneration
See, T. M., LaMarre, A. K., Lee, S. E., & Miller, B. L. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383574 · Cited by 34
The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease
Hendriksz, C. J., Anheim, M., Bauer, P., Bonnot, O., Chakrapani, A., Corvol, J., de Koning, T. J., Degtyareva, А. V., Dionisi‐Vici, C., Doss, S., et al. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1294054 · Cited by 37
Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia
Philtjens, S., Van Mossevelde, S., van der Zee, J., Wauters, E., Dillen, L., Vandenbulcke, M., Vandenberghe, R., Ivanoiu, A., Sieben, A., Willems, C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.011 · Cited by 25
Blue, E., Bis, J. C., Dorschner, M. O., Tsuang, D. W., Barral, S., Beecham, G. W., Below, J. E., Bush, W. S., Butkiewicz, M., Cruchaga, C., et al. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000485503 · Cited by 32
Genetic Modifiers in Neurodegeneration
Jain, N., & Chen-Plotkin, A. S. (2018) · Current Genetic Medicine Reports · doi:10.1007/s40142-018-0133-1 · Cited by 30
Ciani, M., Benussi, L., Bonvicini, C., & Ghidoni, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00506 · Cited by 37
Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations
Sakae, N., Roemer, S. F., Bieniek, K. F., Murray, M. E., Baker, M., Kasanuki, K., Graff‐Radford, N. R., Petrucelli, L., van Blitterswijk, M., Rademakers, R., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50875 · Cited by 34
Self-citationFDG-PET in presymptomatic C9orf72 mutation carriers
Popuri, K., Beg, M. F., Lee, H., Balachandar, R., Wang, L., Sossi, V., Jacova, C., Baker, M. C., Shahinfard, E., Rademakers, R., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102687 · Cited by 34
Self-citationDepletion and activation of microglia impact metabolic connectivity of the mouse brain
Gnörich, J. S., Reifschneider, A., Wind-Mark, K., Zatcepin, A., Kunte, S. T., Beumers, P., Bartos, L. M., Wiedemann, T., Grosch, M., Xiang, X., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02735-8 · Cited by 37
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 31
Gasca‐Salas, C., Masellis, M., Khoo, E., Shah, B., Fisman, D. N., Lang, A. E., & Kleiner‐Fisman, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153852 · Cited by 32
Secreted Progranulin Is a Homodimer and Is Not a Component of High Density Lipoproteins (HDL)
Nguyen, A. D., Nguyen, T. A., Cenik, B., Yu, G., Herz, J., Walther, T. C., Davidson, W. S., & Farese, R. V. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441949 · Cited by 30
Sung, W., Noh, M., Nahm, M., Kim, Y. S., Ki, C., Kim, Y.-E., Kim, H.-J., & Kim, S. H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03039-1 · Cited by 37
Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.
Galimberti, D., & Scarpini, E. A. (2010) · PubMed Central · Cited by 44
Bocchetta, M., Iglesias, J. E., Cash, D. M., Warren, J. D., & Rohrer, J. D. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.12.006 · Cited by 33
Pathological phase transitions in ALS-FTD impair dynamic RNA–protein granules
Nedelsky, N. B., & Taylor, J. P. (2021) · RNA · doi:10.1261/rna.079001.121 · Cited by 33
Myocardial 123I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD
Novellino, F., Bagnato, A., Salsone, M., Cascini, G. L., Nicoletti, G., Arabia, G., Pugliese, P., Morelli, M., Paglionico, S., Cipullo, S., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.009 · Cited by 30
Umbilical cord blood mesenchymal stem cells protect amyloid-β42 neurotoxicityviaparacrine
Kim, J.-Y. (2012) · World Journal of Stem Cells · doi:10.4252/wjsc.v4.i11.110 · Cited by 31
A Model-Based Approach to Understanding Apraxia in Corticobasal Syndrome
Stamenova, V., Roy, É., & Black, S. E. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9079-5 · Cited by 37
Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy
Clippinger, A. K., D’Alton, S., Lin, W.-L., Gendron, T. F., Howard, J. C., Borchelt, D., Cannon, A. D., Carlomagno, Y., Chakrabarty, P., Cook, C. N., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1123-8 · Cited by 28
Self-citationFrontotemporal Lobar Degeneration and MicroRNAs
Piscopo, P., Albani, D., Castellano, A. E., Forloni, G., & Confaloni, A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00017 · Cited by 29
Wilke, C., Gillardon, F., Deuschle, C., Hobert, M. A., Jansen, I. E., Metzger, F. G., Heutink, P., Gasser, T., Maetzler, W., Blauwendraat, C., et al. (2016) · Neurodegenerative Diseases · doi:10.1159/000448896 · Cited by 28
Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells
Lines, G., Casey, J. M., Preza, E., & Wray, S. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103553 · Cited by 29
The right temporal variant of frontotemporal dementia is not genetically sporadic: a case series
Ulugut Erkoyun, H., van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., et al. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201191 · Cited by 24
Martin, S. P., & Leeman-Markowski, B. A. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1287545 · Cited by 36
Frontotemporal dementia: from genetics to therapeutic approaches
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., FABBRO, M. D., & Galimberti, D. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2349286 · Cited by 34
Zhang, K., Li, Y., Guo, Y., Zheng, K.-Y., Yang, Q., Yang, L., Wang, X., Song, Q., Chen, T., Zhuo, M., et al. (2017) · Brain · doi:10.1093/brain/awx265 · Cited by 32
Arrant, A. E., Filiano, A. J., Patel, A. R., Hoffmann, M. Q., Boyle, N. R., Kashyap, S. N., Onyilo, V. C., Young, A. H., & Roberson, E. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.011 · Cited by 28
Delivering progranulin to neuronal lysosomes protects against excitotoxicity
Davis, S. E., Roth, J. R., Aljabi, Q., Hakim, A. R., Savell, K. E., Day, J. J., & Arrant, A. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100993 · Cited by 28
Genetic Diversity in Frontotemporal Dementia
Shpilyukova, Y. A., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Molecular Biology · doi:10.1134/s0026893320010136 · Cited by 32
Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis
Cannon, A. D., Fujioka, S., Rutherford, N. J., Ferman, T. J., Broderick, D. F., Boylan, K., Graff‐Radford, N. R., Uitti, R. J., Rademakers, R., Wszołek, Z. K., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182919059 · Cited by 28
Self-citationSimón-Sánchez, J., Seelaar, H., Bochdanovits, Z., Deeg, D. J. H., van Swieten, J. C., & Heutink, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007494 · Cited by 28
Almeida, S., Gao, F., Coppola, G., & Gao, F. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.001 · Cited by 30
Kong, L., Zhao, Y., Tian, Q., Feng, J., Kobayashi, T., Merregaert, J., & Liu, C.-J. (2016) · The FASEB Journal · doi:10.1096/fj.201600261r · Cited by 30
Buraschi, S., Xu, S., Stefanello, M., Moskalev, I., Morcavallo, A., Genua, M., Tanimoto, R., Birbe, R., Peiper, S. C., Gomella, L. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9556 · Cited by 31
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Ghetti, B., Spina, S., Murrell, J. R., Huey, E. D., Pietrini, P., Sweeney, B., Wassermann, E. M., Keohane, C., Farlow, M. R., & Grafman, J. (2008) · Neurodegenerative Diseases · doi:10.1159/000113706 · Cited by 28
“Mutations in either the Microtubule-Associated Protein Tau (MAPT) gene or the Progranulin (PGRN) gene are associated with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) [”
BackgroundRusina, R., Kovács, G. G., Fiala, J., Hort, J., Ridzoň, P., Holmerová, I., Ströbel, T., & Matěj, R. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-50 · Cited by 29
Gillett, D. A., Wallings, R. L., Huarte, O. U., & Tansey, M. G. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02965-w · Cited by 34
Prevalence of Primitive Reflexes and Parkinsonian Signs in Dementia
Links, K. A., Merims, D., Binns, M. A., Freedman, M., & Chow, T. W. (2010) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100010763 · Cited by 41
Postmorbid learning of saxophone playing in a patient with frontotemporal dementia
Cho, H., Chin, J., Suh, M. K., Kim, Y. J., Kim, Y. J., Ye, B. S., Lee, N. K., Kim, E. J., Seo, S. W., & Na, D. L. (2015) · Neurocase · doi:10.1080/13554794.2014.992915 · Cited by 27
Yan, W., Ding, A. H., Kim, H.-J., Zheng, H., Wei, F., & Ma, X. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600862 · Cited by 29
Nuthikattu, S., Milenković, D., Rutledge, J. C., & Villablanca, A. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-55533-9 · Cited by 28
Zheng, X., Mi, T., Wang, R., Zhang, Z., Li, W., Zhao, J., Yang, P., Xia, H., & Mao, Q. (2022) · Glia · doi:10.1002/glia.24175 · Cited by 29
Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis
Clayton, E. L., Huggon, L., Cousin, M. A., & Mizielinska, S. (2024) · Brain · doi:10.1093/brain/awae074 · Cited by 27
Mouse Models of Neurodegenerative Diseases: Criteria and General Methodology
Janus, C., & Welzl, H. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-058-8_19 · Cited by 30
ESCRT, autophagy, and frontotemporal dementia
Lee, J., & Gao, F. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.12.827 · Cited by 32
Role of Progranulin as a Biomarker for Alzheimer's Disease
Sleegers, K., Brouwers, N., & Van Broeckhoven, C. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.82 · Cited by 27
Clinical genetics of Parkinson's disease and related disorders
Wider, C. W., & Wszołek, Z. K. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70007-5 · Cited by 32
Early Neuropsychological Characteristics of Progranulin Mutation Carriers
Hallam, B. J., Jacova, C., Hsiung, G.-Y. R., Wittenberg, D., Sengdy, P., Bouchard-Kerr, P., Slack, P., Rademakers, R., Baker, M., Chow, T. W., et al. (2014) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617714000551 · Cited by 27
Self-citationHardt, S., Heidler, J., Albuquerque, B., Valek, L., Altmann, C., Wilken‐Schmitz, A., Schäfer, M. K. E., Wittig, I., & Tegeder, I. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.014 · Cited by 28
Chen, Q., & Kantarci, K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00080 · Cited by 29
Graham, A., & Hodges, J. R. (2008) · Psychiatry · doi:10.1016/j.mppsy.2007.11.008 · Cited by 30
Xu, Z., Shabestari, S. K., Barannikov, S., Bieniek, K. F., Blurton-Jones, M. M., Palavicini, J. P., & Han, X. (2025) · Nature Communications · doi:10.1038/s41467-025-64161-z · Cited by 39
Ridolfi, E., Barone, C., Scarpini, E. A., & Galimberti, D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/939786 · Cited by 34
Nascimento, C. F., Nunes, P. V., Rodriguez, R. D., Takada, L. T., Suemoto, C. K., Grinberg, L. T., Nitríni, R., & Lafer, B. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.04.008 · Cited by 31
Deciphering Neurodegenerative Diseases Using Long-Read Sequencing
Su, Y., Fan, L., Shi, C., Wang, T., Zheng, H., Luo, H., Zhang, S., Hu, Z., Fan, Y., Dong, Y., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012466 · Cited by 28
Defects of Nutrient Signaling and Autophagy in Neurodegeneration
Ondaro, J., Hernández-Eguiazu, H., Garciandia-Arcelus, M., Loera‐Valencia, R., Rodríguez-Gómez, L., Jiménez-Zúñiga, A., Goikolea, J., Rodriguez‐Rodriguez, P., Ruiz‐Martínez, J., Moreno, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.836196 · Cited by 30
Trojsi, F., Monsurrò, M. R., Esposito, F., & Tedeschi, G. (2012) · Neural Plasticity · doi:10.1155/2012/473538 · Cited by 25
Progranulin promotes activation of microglia/macrophage after pilocarpine-induced status epilepticus
Zhu, S., Tai, C., Petkau, T. L., Zhang, S., Liao, C., Dong, Z., Wen, W., Chang, Q., Wang, Y. T., MacVicar, B. A., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.023 · Cited by 30
A network of RNA and protein interactions in Fronto Temporal Dementia
Fontana, F., Siva, K., & Denti, M. A. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00009 · Cited by 26
Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration
Gozal, Y. M., Seyfried, N. T., Gearing, M., Glass, J. D., Heilman, C. J., Wuu, J., Duong, D. M., Cheng, D., Xia, Q., Rees, H. D., et al. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-82 · Cited by 29
Primary Progressive Aphasia: Relationship Between Gender and Severity of Language Impairment
Rogalski, E. J., RADEMAKER, A. W., & Weıntraub, S. (2007) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e31802e3bae · Cited by 28
Dobson‐Stone, C., Luty, A. A., Thompson, E. M., Blumbergs, P. C., Brooks, W. S., Short, C. L., Field, C. D., Panegyres, P. K., Hecker, J. R., Fifita, J. A., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1078-9 · Cited by 33
Mutational analysis of PRNP in Alzheimer’s disease and frontotemporal dementia in China
Zhang, W., Jiao, B., Xiao, T., Pan, C., Liu, X., Zhou, L., Tang, B., & Shen, L. H. (2016) · Scientific Reports · doi:10.1038/srep38435 · Cited by 28
Petkau, T. L., Blanco, J., & Leavitt, B. R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.012 · Cited by 24
Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice
Johnson, N. R., Condello, C., Guan, S., Oehler, A., Becker, J., Gavidia, M., Carlson, G. A., Giles, K., & Prusiner, S. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717193114 · Cited by 26
Narendra, D. P., Guillermier, C., Gyngard, F., Huang, X., Ward, M. E., & Steinhauser, M. L. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201901097 · Cited by 27
Progranulin gene mutation with an unusual clinical and neuropathologic presentation
Wider, C. W., Uitti, R. J., Wszołek, Z. K., Fang, J. Y., Josephs, K. A., Baker, M., Rademakers, R., Hutton, M. L., & Dickson, D. W. (2008) · Movement Disorders · doi:10.1002/mds.22065 · Cited by 28
Self-citationNew Genes, New Dilemmas: FTLD Genetics and Its Implications for Families
Goldman, J. S., Adamson, J. L., Karydas, A., Miller, B. L., & Hutton, M. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507306662 · Cited by 35
Self-citationAlzheimer's disease and frontotemporal dementia: prospects of a tailored therapy?
Götz, J., Ittner, L. M., & Schönrock, N. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00615.x · Cited by 32
Alquézar, C., Esteras, N., de la Encarnación, A., Alzualde, A., Moreno, F., de Munaín, A. L., & Martín‐Requero, Á. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.021 · Cited by 30
Therapeutic and diagnostic challenges for frontotemporal dementia
Dâ€TMAlton, S., & Lewis, J. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00204 · Cited by 26
Granulin in Frontotemporal Lobar Degeneration: Molecular Mechanisms of the Disease
Karamysheva, Z. N., Tikhonova, E. B., & Karamyshev, A. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00395 · Cited by 26
Cooper, O., Hallett, P. J., & Isacson, O. (2022) · FEBS Journal · doi:10.1111/febs.16638 · Cited by 28
Zhang, T., Feng, T., Wu, K., Guo, J. D., Nana, A. L., Yang, G., Seeley, W. W., & Hu, F. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02578-w · Cited by 29
The Role of PGRN in Alzheimer’s Disease
Jing, H., Tan, M., Yu, J., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9358-0 · Cited by 27
Significance and limitation of the pathological classification of TDP ‐43 proteinopathy
Arai, T. (2014) · Neuropathology · doi:10.1111/neup.12138 · Cited by 32
MicroRNAs in neurodegenerative disorders
Junn, E., & Mouradian, M. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11296 · Cited by 27
Alquézar, C., Esteras, N., Bartolomé, F. B., Merino, J. J., Alzualde, A., de Munaín, A. L., & Martín‐Requero, Á. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.020 · Cited by 30
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.